Industry Doctorate Program (CHERE)
Project Member(s): De Abreu Lourenco, R.
Funding or Partner Organisation: NOVARTIS AUSTRALIA PTY LIMITED (Novartis Australia)
NOVARTIS AUSTRALIA PTY LIMITED (Novartis Australia)
Start year: 2020
Summary: Assessing the need for a new framework to evaluate the cost-effectiveness of cell and gene therapies
FOR Codes: Health economics , Health Economics, Health Policy Economic Outcomes, Health Policy Evaluation, Evaluation of health and support services not elsewhere classified